Company · Oxford
Oxford Biotherapeutics LTD
Research and experimental development on biotechnology
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Oxford Biotherapeutics LTD. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 18
- John George Mchutchison 2017-2023 View profile
- Daniel Thomas Bradley 2016-2020 View profile
- Shawn Cline Tomasello 2015-2020 View profile
- Dr Thomas Curtis Reynolds 2014-2016 View profile
- Bryan Geoffrey Morton 2013-2014 View profile
- Jonathan Alexander Terrett 2013-2014 View profile
- Dr Esteban Pombo-Villar 2012-2015 View profile
- Dr Colin Glenn Begley 2012-2017 View profile
- Dr Michael Moore 2009-2013 View profile
- Christopher Richard Hibberd 2007-2014 View profile
- Eliot Richard Forster 2006-2015 View profile
- Jeffrey Roger Warren 2005-2011 View profile
- Dr Martin Paul Barnes 2005-2008 View profile
- Albert Platt 2004-2005 View profile
- Maria Juliet Livadiotis 2013-2014 View profile
- Andrew Pryce Rigby 2013-2016 View profile
- Dr Henry John Lamble 2008-2013 View profile
- Alexandra Zimmerman 2004-2005 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Research and experimental development on biotechnology; Other research and experimental development on natural sciences and engineering; Other professional, scientific and technical activities n.e.c.
- Incorporated
- 24/11/2003
- Registered office
- Oxford
- Previous names
- Oxford Genome Sciences (UK) Limited (until 26/11/2008)
Ownership
Owned by (3) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- South East Growth Fund Managers Limited
50-75% shares · notified 2018-11-24 - GKF Wealth Management Limited
25-50% voting · notified 2018-11-24 - Share Nominees Limited ceased 2018-11-24
25-50% shares (trust), 25-50% voting (trust) · notified 2016-04-06
Group
- Oxford Biotherapeutics LTD
is controlled by South East Growth Fund Managers Limited
Evidence
active 50-75% shares · notified 2018-11-24 · source: Companies House PSC register - South East Growth Fund Managers Limited
is controlled by West Midlands Enterprise (Investments) Limited
Evidence
active 25-50% shares, 25-50% voting · notified 2016-04-06 · source: Companies House PSC register - West Midlands Enterprise (Investments) Limited
is controlled by West Midlands Enterprise Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - West Midlands Enterprise Limited
is controlled by WME Group Limited
Evidence
active 75-100% shares, 75-100% voting · notified 2016-04-06 · source: Companies House PSC register - WME Group Limited
is controlled by Ian Martyn Booth
Evidence
active 25-50% voting · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by Ian Martyn Booth.
10 other companies in this group
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Financials
- Net assets
- £2,147,579
- Total assets
- £3,465,227
- Cash
- £4,757,244
- Employees
- 4,958,396
- Turnover
- Not reported (small or micro-entity accounts)
- Profit/loss
- £3,560,161
Figures from accounts filed at Companies House (iXBRL), period ending 2024-12-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
4 directors on the board
- Rohlff, Christian, Doctor Director · appointed 2003
- Jason Lee Gould Director · appointed 2020
- Bizzari, Jean Pierre, Doctor Director · appointed 2016
- Bernd Robert Seizinger Director · appointed 2016
Directors past 6 years
- Rohlff, Christian, Doctor Director · appointed 2003
- Bizzari, Jean Pierre, Doctor Director · appointed 2016
- Bernd Robert Seizinger Director · appointed 2016
First-time vs portfolio directors
First-time (3)
- Rohlff, Christian, Doctor Director · appointed 2003
- Bizzari, Jean Pierre, Doctor Director · appointed 2016
- Bernd Robert Seizinger Director · appointed 2016
Portfolio (1)
- Jason Lee Gould Director · appointed 2020
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Several long-serving directors could step down together
Where to look Suggested search: succession planning for long-tenured seats.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 04974481
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 30/09/2027
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data